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Cocaine and the Dopamine Hypothesis of Addiction 






Dopamine is the primary neurotransmitter associated with addiction. Among the drugs 
that impact dopamine function, cocaine notably causes long-term blunting of dopamine release. 
The “blunted-dopamine hypothesis” explains the behaviors of addiction via cocaine’s blunting 
effects. In a non-addicted brain, dopamine acts in the midbrain reward system to regulate 
pleasure and related emotions. The brain responds to rewarding stimuli by mobilizing 
dopaminergic neurons to release dopamine, causing the pleasure associated with eating, 
gambling, and drug use. Notable structures involved in dopamine pathways are the dorsal and 
ventral striata, the nucleus accumbens (a part of the ventral striatum), and the ventral tegmental 
area, where high concentrations of dopamine receptors are located. Though different dopamine 
receptor types impact addiction in different ways, D1 receptors are most involved in cocaine 
addiction.  
Amphetamine and other stimulants directly cause the brain to release dopamine. By 
increasing the rate at which neurons generate action potentials and the intensity of the action 
potentials generated, amphetamine significantly increases dopamine levels in the striatum. 
Amphetamine is therefore highly useful in the field of dopamine research, as researchers can 
directly induce dopamine release with their application. Cocaine also increases dopamine levels 
within the striatum by inhibiting the dopamine active transporter, the protein that removes 
dopamine from the synaptic cleft after it has been released. Dopamine levels are therefore greater 
following a cocaine-mediated dopamine release. These changes to dopamine function over time 
facilitate the changes to neurobiochemistry that promote cocaine addiction.
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Introduction: Dopamine, the Brain, and Addiction 
Though addiction involves the complex “molecular choreography” of thousands of 
biochemical components, none is more renowned for its involvement than the neurotransmitter 
dopamine. Figure 1 shows the structure of dopamine, an 
endogenous molecule derived from the amino acid tyrosine 
(Biosynthesis section, para. 1). Dopamine acts as a neural 
signaling molecule, a neurotransmitter, that plays a critical 
role in the brain’s “reward system” (Washington, 2017, 
para. 1).   
Like all neurotransmitters, dopamine is produced 
and released by neurons and causes its specific response by 
binding to dopamine receptors on other neurons (Washington, 2017, Biosynthesis section, para. 
1; Release from Neurons section, para. 1). The dopamine reward system facilitates “incentive 
salience”, which creates feelings of “want” and desire, and operant conditioning, specifically 
positive reinforcement (Nutt et al., 2015, p. 305). By inciting pleasure in response to positive (i.e. 
rewarding) stimuli, dopamine inspires repeated consumption of substances that cause pleasure (e. 
g. food) and repeated practice of activities that do the same (e. g. sex, gambling; Di Chiara & 
Bassareo, 2007, p. 72).  
The system that controls reward, and therefore many aspects of addiction, spans many 
parts of the brain, involving diverse brain structures and varied ligands (Washington, 2017, Role 
in Behavior section, para. 1). Dopamine is therefore not the sole neurotransmitter through which 
the reward system acts. However, dopamine is notable as the “chief” neurotransmitter because 
rewarding stimuli elicit a release of dopamine (Nutt, Lingford-Hughes, Erritzoe, and Stokes, 
 





Note: Adapted from Washington, 





2015, p. 305). Cocaine, an addictive drug 
associated with long-term changes in 
dopamine pathways, acts most 
significantly within the dorsal and ventral 
striatum, the latter of which contains the 
nucleus accumbens (NAc; Singer & 
Robinson, 2014, para. 1; Washington, 
2017, Role in Behavior section, para. 1). 
The ventral tegmental area (VTA), as the 
origin of dopamine, is also important to 
addiction because dopamine activity is 
modulated by this region (Singer & 
Robinson, 2014, Brain and neuronal 
activity section, para. 1). Figure 2 shows 
the location of dopamine pathways in the 
brain, including the striatum, the NAc, 
and the VTA.  
Dopamine interacts with neurons 
that contain dopamine receptors; this is 
the factor that forms dopamine pathways 
from disparate neurons. An example of a 
dopamine receptor can be seen in figure 
3. All dopamine receptors are 
Figure 2: Dopamine pathways in the brain 
 
 
Note: Adapted from Organically in Tune. (2014). 
The organic effects of dopamine and the brain’s 
reward system.  
Figure 3: Dopamine transporter 
 
Note: Adapted from Ritz, M. C., Lamb, R. J., 
Goldberg, S. R., & Kuhar, M. J. (1987). Cocaine 
receptors on dopamine transporters are related to 




transmembrane proteins, but they are not homogeneous. There are five classes of dopamine 
receptor, each with unique properties and distributions throughout the brain, though they can be 
broadly grouped according to similarities in structure and function (Missale, Nash, Robinson, 
Jaber, and Caron, 1998, p. 191).  
The habitual nature of activities associated with dopamine release is important to 
maintaining homeostasis. However, changes to dopamine pathways resulting from long-term 
drug abuse can also promote addiction. Substances such as cocaine and amphetamine can 
interact with specific receptors on dopaminergic neurons, causing an increase in the amount of 
dopamine found in the striatum (Nutt et al., 2015, p. 305). Amphetamine plays an important role 
in dopamine testing because it causes dopaminergic neurons to release dopamine; it is therefore 
used in multiple studies to induce dopamine release (Martinez et al., 2003). Cocaine, on the other 
hand, inhibits the transporter involved in dopamine uptake, resulting in a greater buildup of 
dopamine in the striatum (Wu, Reith, Kuhar, Carroll, & Garris, 2001). 
Long-term cocaine abuse is associated with significant physiological changes to 
dopamine pathways. In the brains of those addicted to cocaine, dopamine release via the VTA 
into the striatum may be diminished; this is the so-called “blunted dopamine hypothesis” 
(Volkow et al., 2014, p. 1041). According to this hypothesis, physiological changes to the 
addict’s brain promote less dopamine activity in response to rewarding stimuli; this greatly 
decreases dopamine release. Addiction and its attendant behaviors therefore persist as the addict 
attempts to elicit the dopamine-driven pleasure. 
Direct measure of the action of dopamine molecules can be difficult, requiring inventive 
solutions to obtain quantitative data. One common practice in the field of dopamine research is to 
introduce a radioactive ligand that selectively binds to dopamine receptors.  Images generated by 
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positron emission tomography (PET scans) can then monitor the radioligand’s interaction with 
receptors in the brain. By comparing binding of the radioligand before and after a dopamine-
releasing process, such as a drug administration, scientists can indirectly measure dopamine 
release via the amount of radioligand molecules displaced from dopamine receptors. A lower 
amount of bound radioligand signals a higher amount of bound dopamine. 
 
Locations of Dopamine and Drug Action 
Dopamine pathways are not contained within one specific section of the brain; they span 
many areas and involve various neural structures. Because not all dopamine pathways mediate 
reward, only a specific subset of dopamine pathways is implicated in reward and therefore in 
addiction. In a now-seminal work in the field of neural signaling, Olds and Milner (1954) 
mapped out the brain location on which rewarding stimuli act, now relevant as the area of action 
for stimulant drugs. Performing their modelling in rats, the researchers constructed electrodes 
that electrically stimulated various areas of a rat’s brain when the rat pressed a lever (p. 419). 
They then left the rats to their own devices for periods of several hours, allowing the animals to 
press the lever as they chose (p. 420). All rats were given a percentage score that denoted the 
amount of time they spent pressing the lever. Based upon the definition of a rewarding 
stimulus—one that promotes continual behavior to achieve the effects of the stimulus—a higher 
amount of time pressing the lever signaled reward-seeking behavior (Nutt et al., 2015, p. 305). 
Preservation and examination of the rat brains showed that the electrodes that stimulated the 
center of the forebrain (the septal region) were activated most frequently (Olds & Milner, 1954, 
p. 421). Figure 4 (see following page) details the percentage of time rats spent pressing the lever 
to stimulate various areas of the brain. Voltages vary because each rat’s voltage was determined 
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separately—each one is the voltage at 
which behavioral changes are just 
noticeable. Acquisition refers to the 
time during which pressing the lever led 
to electrical stimulation; extinction 
refers to the time when the lever 
produced no stimulation. The extinction 
period acted as a control period, during 
which the rats’ behavior was evaluated 
in the presence of no stimulus. The 
septal region was clearly stimulated 
most frequently during acquisition, 
from 75 to 92 percent of the time. The 
rats’ repeated stimulation of this area 
was a pattern of behavior associated with a rewarding stimulus. The study therefore concluded 
that the brain’s center for reward was most likely located in the center of the forebrain (p. 425). 
Later research, including that of Martinez et al. (2003), confirmed this area as both the center of 
dopamine activity and the target for physiological effects of addictive drugs. Today, this area is 
known to contain the VTA and the adjoining dorsal and ventral striatum (containing the NAc), 
the areas where drug use incites increased dopamine release. 
Another important aspect of dopamine pathways is the type of receptors present. The D1-
like receptors, consisting of the D1 and D5 receptors, are activators of the protein adenylyl 
cyclase (AC; p. 195). AC catalyzes formation of a secondary signaling molecule, adenosine 3’, 
Figure 4: Time Spent by Rats Eliciting Electrical 
Stimulation 
 
Note: Adapted from Olds, J. & Milner, P. (1954). 
Positive reinforcement produced by electrical 
stimulation of septal area and other regions of rat 
brain. Journal of Comparative and Physiological 





(cAMP), to transduce a signal 
(p. 190, 195). The D2-like 
receptors, consisting of D2, 
D3, and D4 receptors, inhibit 
AC to prevent transduction (p. 
190, 195). The D4 and D5 
receptors are not widespread 
within the striatum and are 
therefore not of importance to 
understanding dopamine 
pathways located there (Missale et al., 1998, p. 199). Among the remaining three receptor types, 
D1 receptors appear to be most significant to cocaine effects (p. 1741). Karasinska, George, 
Cheng, and O’Dowd (2005) evaluated cocaine-induced behavioral changes in mice lacking D1 
receptors, D3 receptors, and both D1 and D3 receptors. Wild-type mice with normal receptor 
expression were included as controls. Figure 5 reveals the horizontal movement of mice treated 
with varying doses of cocaine: 5, 10, and 20 milligrams per kilogram of mass. The wild-type 
mice (WT) exhibited clear increases in movement after cocaine administration; this is the 
expected effect of cocaine in mice. The mice lacking D1 receptors exhibited a slight decrease to 
movement, while the mice lacking D3 receptors showed inconsistent responses: movement 
increased for 5 and 20-milligram doses and decreases for the 10-milligram dose. Mice lacking 
both receptor types also exhibited decreased movement for all doses. The study concluded that 
though absence of both receptor types caused changes to the mice’s responses, mice lacking D1 
Figure 5: Movement of cocaine-treated mice  
 
Note: Adapted from Karasinska, J. M. et al. (2005). Deletion 
of dopamine D1 and D3 receptors differentially affects 
spontaneous behaviour and cocaine-induced locomotor 
activity, reward and CREB phosphorylation. European 
Journal of Neuroscience, 22(7), 1741-1750. 
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receptors deviated most from the controls (Karasinska et al., 2005, p. 1748). This conclusion 
determines that D1 receptors are most greatly implicated in the brain’s response to cocaine, 
though D3 receptors (and other D2-like receptors) are also involved. 
 
Amphetamine Causes Dopamine Release 
To study the magnitude of a dopamine release, a dopaminergic neuron must be induced 
to release the neurotransmitter via application of a specific substance. Cocaine is often the study 
of such trials because it decreases the amount of dopamine released in the brains of cocaine 
addicts. Many trials that test cocaine’s blunting effect produce controlled dopamine release via 
administration of amphetamine or similar compounds.  
Martinez et al. (2003) 
demonstrated the dopamine-releasing 
effect of amphetamine in human brains. 
This study used the radioligand 
[11C]raclopride, a radioactively-labelled 
molecule that binds selectively to 
dopamine receptors, to monitor binding 
of dopamine. Subjects underwent PET 
scans before and after amphetamine 
administration, both with 
[11C]raclopride present (p. 286). The 
PET scans, shown in figure 6, show 
binding of [11C]raclopride before amphetamine (left) and after amphetamine (right). Lighter 
Figure 6: PET scans before and after amphetamine 
 
Note: Adapted from Martinez, D. et al. (2003). 
Imaging human mesolimbic dopamine transmission 
with positron emission tomography. Part II: 
amphetamine-induced dopamine release in the 
functional subdivisions of the striatum. Journal of 
Cerebral Blood Flow and Metabolism: Official 
Journal of The International Society of Cerebral 




colors represent lower concentrations of bound [11C]raclopride; the top and bottom rows show 
results in the same subject from slightly different views. The PET scans qualitatively revealed a 
lower amount of [11C]raclopride binding within the striatum and surrounding regions, i.e., areas 
containing dopamine receptors, after amphetamine administration (p. 290). Researchers were 
also able to quantitatively determine reductions to dopamine receptor availability: the least-
impacted region of the dopamine pathway had a mean drop in availability of 6.1 percent, while 
the most-affected region experienced a mean drop of 16.1 percent (p. 291). Fewer available 
receptors indicated greater interaction between dopamine and its receptors and therefore a greater 
concentration of dopamine (p. 289). Martinez and colleagues concluded that amphetamine 
causes dopamine release (2003, p. 292).  
The method of amphetamine’s dopamine-increasing effect in the NAc of rat brains was 
explored in a study by Covey, Bunner, Schuweiler, Cheer, and Garris (2016, p. 1662). The 
results of this study are shown in Figure 7. Monitoring electrical activity with fast-scan cyclic 
voltammetry (FSCV) allowed researchers to evaluate action potentials, or signals that induce a 
Figure 7: Voltage in dopaminergic neurons treated with saline solution and amphetamine 
 
Note: Adapted from Covey, D. P. et al. (2016). Amphetamine elevates nucleus accumbens 
dopamine via an action potential-dependent mechanism that is modulated by 





neuron to release its neurotransmitter. The researchers affixed microelectrodes to the VTA and 
NAc regions, known to be areas of drug-induced dopamine release, to monitor electrical activity 
in those regions (p. 1662). The graph on the left in figure 7, labelled “A”, represented electrical 
activity in the brain when treated by saline solution; this was a control trial. It revealed only 
small changes to voltage within the neuron of interest, specifically those within the VTA and 
NAc. The graph on the right, labelled “B”, revealed greater changes in voltage after 
administration of amphetamine. The peaks in voltage represent action potentials generated by the 
dopaminergic neuron. A neuron’s pattern of generating action potentials is called burst firing; it 
can be seen from this study that amphetamine increases dopamine levels by increasing the burst-
firing rate of dopaminergic neurons. Additionally, action potentials generated after amphetamine 
application were greater in intensity. Therefore, the method by which amphetamine increases 
dopamine levels in the NAc is by increasing the rate and intensity of action potentials generated 
by dopaminergic neurons.  
 
Cocaine Increases Dopamine Levels in the Midbrain  
The physiological changes associated with 
dopamine blunting originate with cocaine’s effects 
upon striatal dopamine levels. Increased dopamine 
levels, resulting from cocaine’s ability to inhibit 
dopamine uptake, cause the neuroadaptations that 
limit dopamine release in long-term cocaine users. 
Figure 8: Structure of cocaine 
 
Note: Adapted from Weil, Andrew T. 
(2014). Cocaine. In AccessScience. 




Figure 8 shows the structure of cocaine. This specific structure allows cocaine to 
competitively inhibit the dopamine active transporter, preventing dopamine uptake and causing 
high levels of dopamine to build up in the striatum (Ritz, Lamb, Goldberg, and Kuhar, 1987, p. 
237). This phenomenon was tested by Wu et al. 
(2001) using voltammetry in rats. Electrodes were 
implanted in areas of the ventral striatum (p. 
6339). Some of the electrodes measured electrical 
activity; others stimulated the brain to induce 
dopamine release. Figure 9 shows the results of 
the study; closed circles (forming darker-colored 
lines, the upper of the two lines for each trial) 
represent cocaine trials and open circles (lighter-
colored, lower) represent control trials. Each 
graph shows the concentration of dopamine over 
time as either a saline solution (control) or 
cocaine was administered. While the overall 
pattern of concentration remains constant, dopamine levels in the striatum increase more with 
cocaine present. The same pattern in dopamine concentration was observed at varying 
frequencies, with a more pronounced effect at lower frequencies. Researchers also quantitatively 
determined the rate of dopamine uptake throughout the trials with the readings obtained through 
electrical measurement and found that dopamine uptake rates decreased significantly in cocaine 
trials (p. 6339, 6342). The study concluded that cocaine increases striatal dopamine levels via 
inhibition of the dopamine active transporter, the agent of dopamine uptake (p. 6345). 
Figure 9: Dopamine releases with and 
without cocaine present 
 
Note: Adapted from Wu, Q. et al. (2001). 
Preferential increases in nucleus 
accumbens dopamine after systemic 
cocaine administration are caused by 
unique characteristics of dopamine 
neurotransmission. The Journal of 
Neuroscience, 21(16), 6338-6347. 
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In addition to inhibition of the dopamine 
transporter, cocaine can also increase dopamine 
levels by inducing release of reserve dopamine. 
Figure 10 shows dopamine concentration 
increases in the striatum of mice following 
administration of cocaine (Venton et al., 2006). 
Dopamine concentration, [DA]p (%), is given as 
a percentage of pre-cocaine dopamine 
concentration. Preceding administration of 
cocaine is administration of α-methyl-p-tyrosine 
(AMPT), a substance that inhibits the enzyme 
tyrosine hydroxylase to severely reduce the 
mice’s ability to produce dopamine from tyrosine. AMPT therefore ensures that released 
dopamine originates from stored reserves. Open circles, labelled as “WT” (wild-type), represent 
mice with normal production of the protein synapsin. Filled triangles, labelled as “TKO” (triple 
knock-out), represent mice in which production of synapsin has been halted via suppression of 
three synapsin genes. Because synapsin is the structural protein that mobilizes vesicles of 
dopamine to be placed into reserves, mice lacking synapsin lack sufficient stored dopamine (p. 
3207). In this study, researchers implanted microelectrodes into the middle of the forebrain and 
used FSCV to locate dopaminergic signals (p. 3208). One set of microelectrodes measured the 
continuing electrical activity of the neurons; another set administered electrical stimulation at a 
level experimentally determined to release maximum dopamine (p. 3208). Several induced 
dopamine releases were performed first without cocaine, then with cocaine present. Cocaine 
Figure 10: Dopamine increases in mice’s 
striata after cocaine administration 
 
Note: Adapted from Venton, B. J. et al. 
(2006). Cocaine increases dopamine 
release by mobilization of a synapsin-
dependent reserve pool. Journal of 




administration to both WT and TKO mice increased dopamine release levels, though the increase 
was significantly greater in WT mice (p. 3208). Because mice without significant reserves had a 
lower cocaine-induced dopamine release, the study concluded that cocaine elevates dopamine 
levels by releasing dopamine from reserve vesicles. 
 
Cocaine Use Causes Dopamine Blunting 
 The dopamine-releasing effects of amphetamine and other stimulants and the dopamine-
increasing effect of cocaine converge in studies that examine cocaine’s effect on dopamine 
release. Based on such studies, a primary physiological effect of cocaine addiction has been 
determined to be decreased dopamine release in response to rewarding stimuli. 
 
 
Martinez et al. (2007) compared controlled dopamine release in two different groups of 
volunteer subjects: 24 active cocaine users and 24 non-cocaine-addicted controls. All regions 
where [11C]raclopride binding was examined were within the striatum, the center of dopamine 
activity. Figure 11 shows the percent change in binding potential (BP) of [11C]raclopride before 
Figure 11: Change in binding potential (BP) of [11C]raclopride before and after induced 
dopamine release in control and cocaine-addicted subjects 
 
Note: Adapted from Martinez, D. et al. (2007). Amphetamine-induced dopamine release: 
Markedly blunted in cocaine dependence and predictive of the choice to self-administer 
cocaine. The American Journal of Psychiatry, 164(4), 622-629.  
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and after application of amphetamine, used to induce dopamine release; “SD” is the standard 
deviation. BP is the ratio of ligands bound to receptors to free ligands; a lower BP indicates 
fewer ligands bound to receptors. Lower BP, as expressed by the negative results of every trial, 
indicated decreased binding of [11C]raclopride to dopamine receptors: [11C]raclopride was 
displaced from the receptors following amphetamine administration due to an increase in striatal 
dopamine levels (p. 1041). However, the decrease in BP was significantly greater in the controls 
than in either “cohort” of cocaine abusers, indicating a greater amount of dopamine release in 
control subjects. The study concluded that dopamine release in cocaine addicts was greatly 
diminished compared to that in non-addicts. A second study by Volkow et al. (2014) used nearly 
identical methods and came to the same conclusion; these results were not an isolated incident. 
This is how cocaine addiction develops: repeated instances of cocaine use markedly 
increase dopamine levels. As time and usage progress, the brain adapts to higher dopamine levels 
in the striatum through physiological changes. The result of these changes is the blunting of 
dopamine release in response to rewarding stimuli. Drug-taking behaviors persist as the affected 
individual attempts to elicit the pleasurable response of a dopamine release, now diminished by 
the drug use that he or she continues to pursue. 
 
Conclusion 
Mapping out any brain activity is a complex and laborious task; dopamine pathways are 
no exception. It has taken numerous studies to pinpoint the location of dopamine action in the 
brain and to connect that action to its roles in pleasure, reward, and conditioning. The neural 
reward system, in which dopamine is the essential element to reward response, was first 
sequenced to the midbrain by Olds and Milner (1954), who determined that rats self-stimulate 
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this area of the brain more than other areas when left to their own devices. Subsequent research 
has specified the involvement of the VTA, the ventral striatum (including the NAc), and the 
dorsal striatum in dopamine pathways.  
Dopamine pathways are connected by neurons containing dopamine receptors. As 
elucidated by Ritz et al. (1987), there are five types of dopamine receptor, categorized by their 
structure and function into two larger subgroups: the D1-like receptors and the D2-like receptors. 
While D1, D2, and D3 receptors are all found within the areas of dopamine activity and all appear 
to have an influence in cocaine addiction, D1 receptors appear to be the most significant 
(Karasinska et al., 2005). 
As a neurotransmitter, dopamine functions by binding to its specific receptors on neurons 
and thereby transmitting a signal to that neuron. This signaling is mediated by action potentials, 
or electrical signals, transmitted the length of neurons. Amphetamine has a notable effect upon 
the action potentials generated by dopaminergic neurons; namely, it increases them. 
Administration of amphetamine has been shown to increase the rate at which dopaminergic 
neurons generate action potentials and the intensity of those action potentials, causing the 
neurons to release more dopamine (Covey et al., 2016). Amphetamine is therefore a highly 
useful drug in dopamine research because it induces dopamine release. 
Cocaine, too, increases dopamine levels in the midbrain. By inhibiting the dopamine 
transporter, cocaine prevents normal uptake of dopamine and ensures that dopamine levels in the 
ventral and dorsal striata are elevated (Wu et al., 2001). Due to this effect, cocaine has long-term 
impacts upon the brain’s ability to release and receive dopamine. Known as the blunted 
dopamine effect, the brains of those addicted to cocaine experience a much-decreased release of 
dopamine when stimulated (Martinez et al., 2007; Volkow et al., 2014). 
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 The progression of cocaine addiction is clearly marked by neurobiochemical alterations 
dopamine pathways. It is unsurprising that dopamine, as the neurotransmitter most involved in 
the brain’s reward system, also plays a key role in the effects of cocaine, an addictive drug 
associated with rewarding effects. The blunted-dopamine hypothesis explains that cocaine 
addiction persists due to the drug’s long-term impact on dopamine pathways, i.e., its ability to 
reduce dopamine release. Cocaine therefore alters the brain’s ability to perceive pleasure and 
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